Coegin Pharma
Sweden - LundPharmaceutical
Focus: Coegin Pharma is a Swedish biotech company founded in 2022 focused on inflammatory targeting through small molecules and peptides in immunology. With 201-500 employees, it operates as an emerging player in a competitive therapeutic space.
Profile data last refreshed 22h ago · AI intelligence enriched 2w ago
Employees
201-500
Open Jobs
0
About Coegin Pharma
AI assessmentNot HiringNo open roles listed right now. Follow Coegin Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
AVX001
Actinic KeratosesClinical Trials (1)
NCT05164393Phase I/IIa Trial to Evaluate AVX001 Gel in Doses of 1% or 3% Compared With Vehicle Over Four Weeks of Field-directed Treatment Period in Adult Subjects With AK
Phase 1/2Help build intelligence for Coegin Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.